Latest Breaking News On - Bio chairman - Page 4 : comparemela.com

Cell and Gene Therapy Portfolio Builder ElevateBio Raises $525M in Financing Cell and gene therapy company ElevateBio has completed a $525 million Series C financing, with plans to use the proceeds toward developing and expanding its technology platforms, growing its network of process development and GMP manufacturing capacity, advancing industry partnerships, and continuing to develop candidates through its portfolio of companies. [ElevateBio] March 15, 2021 Cell and gene therapy company ElevateBio has completed a $525 million Series C financing, with plans to use the proceeds toward developing and expanding its technology platforms, growing its network of process development and GMP manufacturing capacity, advancing industry partnerships, and continuing to develop candidates through its portfolio of companies. [ElevateBio]

United kingdomUnited statesRed mileDavid hallalElevatebio basecampKaran takharInvus groupSoftbank vision fundRedmile groupResearch triangle parkFidelity management research companyFred hutchinson cancer research centerBio chairmanMassachusetts general hospitalEpstein barr virusHuman herpesvirus